Alex Janin retweeted
A wild October surprise. w/ @LizzyLaw_
Alex Janin retweeted
EXCLUSIVE - Top RFK Jr. ally and adviser Calley Means has quit the Trump administration.
Means was frustrated by White House delays of some of Kennedy’s popular food policies and blamed others in the administration for allowing food companies and special interests to have too much sway, people familiar with the matter said.
One of them described him as “disillusioned.” wsj.com/politics/policy/call…
Alex Janin retweeted
Medicaid data show some private-equity-backed chains billed far more hours than rivals. Companies say patient needs guide treatment. on.wsj.com/4z4imEu
Alex Janin retweeted
NEW: I dug into a new class of drugs called "protein degraders" that pharma companies are pouring billions of dollars into, hoping to find a new tool to attack diseases from cancer to Parkinson’s.
wsj.com/health/pharma/big-ph…
Alex Janin retweeted
"Gifts, payments, free meals, and other marketing ploys by pharmaceutical companies heavily influence doctors to prescribe more drugs, choose less appropriate treatments, and drive up prescription costs, according to a systematic review of 93 studies." usrtk.org/healthwire/drug-co…
Alex Janin retweeted
Crazy WSJ data. Between 2022 and 2025, wealth increased 37% for Americans 75 and older, while **decreased** 23% for people under 35.
wsj.com/economy/affluent-and…
Alex Janin retweeted
Context for this HHS inquiry ⬇️
“Kennedy, who for many years worked as an environmental lawyer, successfully petitioned a federal court in 2020 to force the Federal Communications Commission to review its wireless-radiation rules.”
wsj.com/health/rfk-jr-s-heal…
What should we know about wireless exposure?
HHS is seeking public input and scientific evidence on electromagnetic fields, radiofrequency radiation, and potential health effects — including questions about 5G, Wi-Fi, and wireless infrastructure.
Share your input through our Request for Information (RFI) by October 21: regulations.gov/commenton/HH…
Alex Janin retweeted
Alex Janin retweeted
Annual prevalence of GLP-1 RA prescriptions without documentation of a US FDA-approved indication.
onlinelibrary.wiley.com/doi/…
Alex Janin retweeted
Tennessee's failed execution of Christa Pike has resulted in fresh scrutiny of the shaky and secretive supply chain for lethal injection drugs. W/ @AlexLJanin:
wsj.com/health/pharma/botche…
Alex Janin retweeted
NEW with @LizzyLaw_: The Trump administration is rolling out a program aimed at getting Medicare to match drug prices in other countries for certain high-cost drugs
Pharma companies that cut deals with the admin expected to be exempt
wsj.com/health/pharma/trump-…
Alex Janin retweeted
Hello from the MAHA Summit.
A number of reporters denied credentials despite empty press seats.
A security guard first said he needed to escort me everywhere but now has given up I guess.
Alex Janin retweeted
The Danish drugmaker signed a licensing deal for a weight-loss treatment being developed by Hengrui Pharma that could be worth up to $2.6 billion. on.wsj.com/3VgSztO
Alex Janin retweeted
In August, HHS officials were prepared to unveil the definition of ultra-processed food they'd spent months workshopping.
Days before the event, the White House reversed course.
wsj.com/politics/policy/rfk-…
Alex Janin retweeted
SCOOP: OpenAI, Anthropic and security researchers are investigating tens of thousands of incidents - not dozens - in which their frontier models took steps that outside evaluators would consider problematic, sources told Axios.
The sheer volume of incidents found in our reporting indicate that the problem is orders of magnitude more complex than what is currently publicly known and disclosed.
The findings also raise questions about what level of control anyone working on AI development can expect to have over their own technology, and whether these kinds of incidents are becoming synonymous with frontier deployment.
Read my latest for Axios here: axios.com/2026/09/26/openai-…
Alex Janin retweeted
Sen. Kaine (D., Va.) reads our story and asks FDA nominee if she's aware of the plan to revisit the 2021 rule on tobacco applications.
Dr. Heidi Overton says she's not involved in the plans and the administration's goal is to protect kids.
wsj.com/politics/policy/u-s-…
Alex Janin retweeted
NEW exclusive from me:
Health officials moved money out of the Office of Minority Health to help pay for the ballooning costs of RFK Jr.'s security
wsj.com/politics/policy/rfk-…
Alex Janin retweeted
The results for enicepatide reinforce the company’s ambitions to rapidly develop its portfolio of medicines for people with obesity, diabetes and cardiovascular disease. on.wsj.com/4xz7exF
Alex Janin retweeted
Replying to @Roche
@Roche notches impressive P2 data for the GLP-1R-GIPR co-co-agonist Enicepatide #T2D #weightloss roche.com/media/releases/med…
Alex Janin retweeted
NEW: Pharmaceutical Companies Push Trump Administration to Protect China Deals wsj.com/health/pharma/pharma…















